FDA accepts resubmitted BLA for Atara's tabelecleucel with 2027 target date
Go back to FDA accepts resubmitted BLA for Atara's tabelecleucel with 2027 target date| (NASDAQ: ATRA) | Delayed: 9.35 +0.19 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.16 | 52 Week High | $40.80 | |||
| Open | $9.25 | 52 Week Low | $12.45 | |||
| Day High | $9.43 | P/E | N/A | |||
| Day Low | $9.17 | EPS | $0.00 | |||
| Volume | 26,545 | |||||



